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Cinnamon (Cinnamomum zeylanicum, and Cinnamon cassia), the eternal tree of tropical medicine, belongs to the Lauraceae family.
Cinnamon is one of the most important spices used daily by people all over the world. Cinnamon primarily contains vital oils and
other derivatives, such as cinnamaldehyde, cinnamic acid, and cinnamate. In addition to being an antioxidant, anti-inflammatory,
antidiabetic, antimicrobial, anticancer, lipid-lowering, and cardiovascular-disease-lowering compound, cinnamon has also been
reported to have activities against neurological disorders, such as Parkinson’s and Alzheimer’s diseases. This review illustrates the
pharmacological prospective of cinnamon and its use in daily life.
1. Introduction
The bark of various cinnamon species is one of the most
important and popular spices used worldwide not only for
cooking but also in traditional and modern medicines. Over-
all, approximately 250 species have been identified among the
cinnamon genus, with trees being scattered all over the world
[1, 2].
Cinnamon is mainly used in the aroma and essence
industries due to its fragrance, which can be incorporated
into different varieties of foodstuffs, perfumes, andmedicinal
products [3]. The most important constituents of cinnamon
are cinnamaldehyde and trans-cinnamaldehyde (Cin), which
are present in the essential oil, thus contributing to the
fragrance and to the various biological activities observed
with cinnamon [4]. A study on Cinnamomum osmophloeum
(C. osmophloeum) indicated that the essential oil from cin-
namon leaves contains a high level of Cin. Consequently,
C. osmophloeum is also used as an alternative spice for C.
cassia [5]. One of the major constituents of essential oil
extracted from C. zeylanicum named (E)-cinnamaldehyde
has an antityrosinase activity [6], while cinnamaldehyde is
the principal compound responsible for this activity [7].
Cinnamon bark contains procyanidins and catechins [8].
The components of procyanidins include both procyani-
din A-type and B-type linkages [9–11]. These procyanidins
extracted from cinnamon and berries also possess antioxi-
dant activities [10, 12].
2. Methodology
The current review was conducted using a complete and
organized search of the available literature on the medicinal
plant cinnamon from 1982 to 2013. The searches were
performed using various databases, including PubMed
(http://www.ncbi.nlm.nih.gov/pubmed), Science Direct
(http://www.sciencedirect.com/), Scopus (http://www.scopus
.com/), Scirus (http://www.scirus.com/), and Google Scholar
(http://www.scholar.google.com/).
3. Traditional Uses
In addition to being used as a spice and flavoring agent,
cinnamon is also added to flavor chewing gums due to its
mouth refreshing effects and ability to remove bad breath [13].
Cinnamon can also improve the health of the colon, thereby
reducing the risk of colon cancer [14].
Cinnamon is a coagulant and prevents bleeding [15].
Cinnamon also increases the blood circulation in the uterus
and advances tissue regeneration [16]. This plant plays a vital
role as a spice, but its essential oils and other constituents also
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have important activities, including antimicrobial [17–20],
antifungal [21], antioxidant [22–26], and antidiabetic [27–33].
Cinnamon has been used as anti-inflammatory [34–36],
antitermitic [36], nematicidal [37, 38], mosquito larvicidal
[39], insecticidal [40], antimycotic, [40–43] and anticancer
agent [44–47]. Cinnamon has also been traditionally used as
tooth powder and to treat toothaches, dental problems, oral
microbiota, and bad breath [48, 49].
4. Chemical Constituents
Cinnamon consists of a variety of resinous compounds,
including cinnamaldehyde, cinnamate, cinnamic acid, and
numerous essential oils [50] (Table 1). Singh et al. [51]
reported that the spicy taste and fragrance are due to the
presence of cinnamaldehyde and occur due to the absorption
of oxygen. As cinnamon ages, it darkens in color, improving
the resinous compounds [51]. Sangal reported various phys-
iochemical properties of cinnamon (Table 2).The presence of
a wide range of essential oils, such as trans-cinnamaldehyde,
cinnamyl acetate, eugenol, L-borneol, caryophyllene oxide,
b-caryophyllene, L-bornyl acetate, E-nerolidol, 𝛼-cubebene,
𝛼-terpineol, terpinolene, and 𝛼-thujene, has been reported
[35, 36].
The chemical structures of some important constituents
of cinnamon are shown in Figures 1, 2, 3, 4, and 5.
5. Antioxidant Activity
Antioxidant compounds present in foodstuffs play a vital
role in human life, acting as health-protecting agents. In
addition to this role, antioxidants are one of the key additives
used in fats and oils. Even in the food processing industry,
Table 1: Chemical constituents of different parts of cinnamon [136]
(Vangalapati et al., 2012 [2]).
Part of the plant Compound
Leaves Cinnamaldehyde: 1.00 to 5.00%
Eugenol: 70.00 to 95.00%
Bark Cinnamaldehyde: 65.00 to 80.00%
Eugenol: 5.00 to 10.00%
Root bark Camphor: 60.00%
Fruit trans-Cinnamyl acetate (42.00 to 54.00%)and caryophyllene (9.00 to 14.00%)
C. zeylanicum buds
Terpene hydrocarbons: 78.00%
alpha-Bergamotene: 27.38%
alpha-Copaene: 23.05%
Oxygenated terpenoids: 9.00%
C. zeylanicum flowers
(E)-Cinnamyl acetate: 41.98%
trans-alpha-Bergamotene: 7.97%
Caryophyllene oxide: 7.20%
antioxidants have been used to delay or prevent food spoilage.
Spices andmedicinal plants have received rapid consideration
as sources of beneficial antioxidants against various diseases
[52]. Antioxidants have been considered the most important
drivers in the progress and existence of humans, as they
respond to free radicals anddamage inmetabolic diseases and
age-related syndromes of humans and other animals [53, 54].
Mancini-Filho et al. reported various extracts of cin-
namon, such as ether, aqueous, and methanolic extracts
that have shown considerable antioxidant activities [22].
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A study on rats reported that the administration of the bark
powderof C. verum (10%) for 90 days produced antioxidant
activities as indicated by cardiac and hepatic antioxidant
enzymes, lipid conjugate dienes, and glutathione (GSH) [55].
A research group reported that cinnamon oil potentially
exhibits superoxide-dismutase- (SOD-) like activity as indi-
cated by the inhibition of the inhibiting capacity of pyrogallol
autoxidation [56].
The aqueous and alcoholic extract (1 : 1) of cinnamon
potentially significantly inhibits fatty acid oxidation and
lipid peroxidation in vitro [23]. Different flavonoids isolated
from cinnamon have free-radical-scavenging activities and
antioxidant properties [57]. A study of the inhibitory effects of
cinnamaldehyde andother compounds of cinnamononnitric
oxide production revealed that cinnamaldehyde possesses
potential activity against the production of nitric oxide as
well as the expression of inducible nitric oxide. The highest
inhibitory activities were reported as 81.5%, 71.7%, and 41.2%
at 1.0, 0.5, and 0.1 𝜇g/𝜇L, respectively [58]. Lin et al. reported
the in vivo antioxidant activity of two different extracts,
the ethanolic and hot water extracts of the dry bark of C.
cassia. The ethanolic extract of C. cassia exhibited signifi-
cant inhibition (96.3%) compared to the natural antioxidant
𝛼-tocopherol (93.74%) [59]. Overall, cinnamon exhibited
higher antioxidant activities compared to that of other dessert
spices [60].
The essential oils and some of the major compounds pre-
sent in cinnamon, including (E)-cinnamaldehyde, eugenol,
and linalool, were investigated in reference to peroxynitrite-
induced nitration and lipid peroxidation. Eugenol and the
essential oils were more effective than the other two com-
pounds [61]. In a comparative study among 26 spices, cinna-
mon showed the highest antioxidant activity, indicating that
it can be applied as an antioxidant used in foods [62]. Another
study investigated the effectiveness of a mixture of spices on
oxidative stress markers as well as the antioxidant activity in
high fructose-fed insulin-resistant rats. The mixture, which
consisted of 1 g/100 g cinnamon bark, showed a significant
antioxidant activity compared to the fructose alone group
[63]. Volatile oils from C. zeylanicum showed significant
biological activities [64].
Forty-one different volatile compounds in the bark oil
of cinnamon have been identified and were found to vary
significantly in percentage composition depending on the
growth stages and segments of the C. cassia tree [65].
To extract essential oil for industrial use, the yields and
compositions of bark oil during Cinnamomum cassia growth
(1–3 years old for the branch bark and 5–12 years old for the
stem bark) were determined. These researchers also found
that the branch bark fraction tended to yield more essential
oil compared to the entire branch, indicating that selecting
the bark based on the tree growth stages as well as separating
the stem barks into top, center, and lower sections within
a tree can significantly improve the extraction efficiency of
essential oils.
A preliminary study on C. malabatrum leaves was con-
ducted in various types of extracts (n-hexane, alcoholic, and
aqueous extracts) to determine the presence of phenolic
compounds, which indicate antioxidant activity. All of the
extracts had moderate amounts of phenolic compounds and
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Figure 5: Other miscellaneous compounds containing oxirane, 2-pyranone, and pyran groups.
Table 2: Physicochemical properties of cinnamon (Sangal., 2011 [1]).
Parameter Leaf oil Bark oil
Specific gravity (20∘C) 1.030–1.050 1.010–1.030
Optical rotation (∘) (20∘C) 1∘96󸀠–0∘40󸀠 Slightly laevorotatory
Refractive index (20∘C) 1.529–1.537 1.573–1.591
Aldehyde content 4% 65–76%
Eugenol content 77.3–90.5% 4–10%
Solubility characteristics Soluble in 1.5 volumes of 70% alcohol Soluble in 2.0–3.0 volumes of 70% alcohol
showed potential activity against hydrogen peroxide, nitric
oxide, and lipid peroxide free radicals [66]. A recent study
investigated the antioxidant properties of several parts (i.e.,
the leaves, barks, and buds) of C. cassia. The ethanolic extract
of all of the plant parts had significant antioxidant properties
compared with the extraction using the supercritical fluid
[67]. The supercritical extracts showed decreased activity
compared to the ethanol extracts, indicating that the active
components are constituents with high polarity.
C. tamala has potential antioxidant activities in diabetic
rats [68], while C. osmophloeum, a species from Taiwan,
has significant in vitro and in vivo antioxidant activities
under oxidative stress [69]. The antioxidant activity of C.
zeylanicum has been investigated using various methods. In
addition to the antioxidant activity, cinnamon can be used as
a preservative in cakes and other food products [70]. A recent
study reported that pectin film coated with cinnamon leaf
extract yielded high antioxidant and antibacterial activities
[71]. Dong et al. reported that cinnamaldehyde (E) extracted
from C. cassia is the main compound and is present in levels
as high as 72.7% compared to other volatile components
[72]. Cinnamaldehyde (E) is well known for its antityrosi-
nase activity [6, 73]. Currently, much attention is given to
tyrosinase inhibitors due to their actions in suppressing
hyperpigmentation as well as the unsightly browning effects
observed in mushrooms, fruits, and vegetables when they
are exposed to sunlight or air. Hence, antityrosinase agents
are associated with a wide range of applications, such as
cosmetics, medicine, and food [74, 75].
6. Anti-Inflammatory Activities
Several studies on medicinal plants and their components
have indicated the anti-inflammatory activities of cinnamon
[76–81]. Various studies reported the anti-inflammatory
activity of cinnamon and its essential oils [34–36]. To date,
there are several flavonoid compounds (e.g., gossypin,
gnaphalin, hesperidin, hibifolin, hypolaetin, oroxindin,
and quercetin) that have been isolated and have anti-
inflammatory activities [82–86].
A recent study reported that 2󸀠-hydroxycinnamaldehyde
isolated from C. cassia bark exhibited an inhibitory effect on
the production of nitric oxide by inhibiting the activation of
the nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-𝜅B), indicating that this substance can potentially
be used as an anti-inflammatory agent [87]. The ethanolic
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extract of C. cassia showed significant anti-inflammatory
effects by reducing the activation of Src/spleen-tyrosine-
kinase- (Src/Syk-) mediated NF-𝜅B [88, 89]. Various com-
pounds contained in C. ramulus showed anti-inflammatory
effects by suppressing the expression of inducible nitric
oxide synthesis (iNOS), cyclooxygenase-2 (COX-2), and
nitric oxide (NO) production in the central nervous sys-
tem (CNS). By this mechanism, C. ramulus could be a
potential source for the therapeutic treatment or prevention
of inflammation-mediated neurodegenerative diseases [90].
Furthermore, the aqueous extract of cinnamon decreases the
lipopolysaccharide-induced tumor necrosis factor-𝛼 levels in
the serum [91].
7. Neurological Disorders
Cinnamophilin is a novel thromboxane A2 receptor antago-
nist isolated fromC. philippinensis [92]. A study reported that
cinnamophilin confers protection against ischemic damage
in rat brains when administered at 80mg/kg at different
time intervals (2, 4, and 6 h) after insult. The effects were
found to have a considerable effect (by 34–43%) on abridged
brain infarction [93] and further enhance neurobehavioral
outcomes. Cinnamophilin also dramatically condenses the
oxygen glucose deprivation-induced neuronal damage in
organotypic hippocampal slices in experimental rats. A sub-
stance called procyanidin type-A trimer (trimer 1) isolated
from cinnamon’s water-soluble extract showed that trimer
1 may reduce cell swelling by controlling the movement of
intracellular calcium [Ca2+]i [94]. Trimer 1 also considerably
alleviates the oxygen glucose deprivation-induced diminish-
ing effects on glutamate uptake. The protective effects of
trimer 1 in attenuating the diminution in glutamate uptake
are possibly arbitrated via their effects on the mitochondria
[94].
Parkinson’s disease (PD) is the second major widespread
neurodegenerative disorder after Alzheimer’s disease, with
a prevalence of 2% in people 65 years and older [95].
PD protein 7 (PARK7) is an autosomal recessive form of
early-onset parkinsonism caused by alterations in the DJ-
1 gene [96]. Khasnavis and Pahan reported that sodium
benzoate, a cinnamon metabolite, upregulates DJ-1 by mod-
ulating mevalonate metabolites [97, 98]. Cinnamon and its
metabolite sodium benzoate also upregulate the neurotropic
factors BDNF (brain-derived neurotropic factors) as well as
neurotrophin-3 (NT-3) in the mouse central nervous system
[99]. PARK7 is one of the main neuroprotective proteins that
protects cells from damage and from the further detrimental
effects of oxidative stress; therefore, this protein may be
an effective molecule that can be incorporated into the
therapeutic intervention of Parkinson’s disease [98].
A natural compound isolated from cinnamon extract
(CEppt) significantly reduces the formation of toxic 𝛽-
amyloid polypeptide (A𝛽) oligomers and prevents its toxicity
on neuronal pheochromocytoma (PC12) cells [100]. The
study indicated that CEppt resolved the reduced permanence,
fully improved deficiencies in locomotion, and totally eradi-
cated the tetrameric species of A𝛽 in the brain of the flymodel
of Alzheimer’s disease, leading to a noticeable reduction in
the 56 kDa A𝛽 oligomers, reducing plaques and improv-
ing the cognitive performance of transgenic mice models
[100].
Another study reported that the aqueous extract of C.
zeylanicum can reduce tau aggregation and filament for-
mation, two of the main features of Alzheimer’s disease.
The extract can also encourage the complete fragmentation
of recombinant tau filaments and cause the considerable
modification of the morphology of paired helical filaments
from Alzheimer’s disease brain [101], indicating the potential
of cinnamon in the treatment of Alzheimer’s disease.
8. Antidiabetic Activity
A substance from cinnamon has been isolated and coined
as “insulin-potentiating factor” (IPF) [102], while the antidi-
abetic effects of cinnamon bark have been shown in
streptozotocin-induced diabetic rats [33]. Several studies
have also revealed that cinnamon extracts lower not only
blood glucose but also cholesterol levels [103–107].
A study comparing the insulin-potentiating effects of
many spices revealed that the aqueous extract of cinnamon
was 20-fold higher than the other spices [108]. Methylhy-
droxychalcone polymer (MHCP) is the purified polymer
of hydroxychalcone with the ability to stimulate glucose
oxidation [30, 109]. Anderson et al. isolated and character-
ized the polyphenol type-A polymers from cinnamon and
found that these substances act as insulin-like molecules
[9]. Following this characterization, a new compound from
hydroxycinnamic acid derivatives named naphthalenemethyl
ester, which has blood glucose-lowering effects, has been
identified [27], further confirming cinnamon’s antidiabetic
effects.
Several polyphenols have been isolated from cinnamon.
These polyphenols include rutin (90.0672%), catechin (1.9%),
quercetin (0.172%), kaempferol (0.016%), and isorhamnetin
(0.103%) [67, 110]. Cao et al. (2007) demonstrated that the
aqueous extract of cinnamon containing polyphenols puri-
fied by high performance liquid chromatography (HPLC)
showed insulin-like activity [111]. The aqueous extract of
cinnamon markedly decreased the absorption of alanine in
the rat intestine. Alanine plays a vital role in gluconeogenesis,
is altered back to pyruvate in the liver, and is utilized
as a substrate for gluconeogenesis [112]. However, another
study conducted on diabetic postmenopausal women supple-
mented with cinnamon showed poor glycemic control [113],
even though cinnamon is generally believed to be useful for
diabetes. However, it is plausible that differences in the dose
of cinnamon used, as well as baseline glucose and lipid levels,
have led to these variations.
In a recent study [114], suitable doses of cinnamon (5, 10,
and 20mg/kg) of the linalool chemotype were found to help
with glycemic control in diabetics due to enhanced insulin
secretion. It is plausible that the amelioration of oxidative
stress and the proinflammatory environment in the pancreas
may confer protection to pancreatic 𝛽 cells [114], which
should be further investigated.
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9. Antimicrobial Activity
To date, several antimicrobial activities of cinnamon and its
oils have been reported in various studies [20, 28, 115]. For
example,Matan et al. reported the effects of cinnamon oils on
different bacterial (Pediococcus halophilus and Staphylococcus
aureus), fungal (Aspergillus flavus, Mucor plumbeus, Penicil-
lium roqueforti, andEurotium sp.), and yeast species (Candida
lipolytica, Pichia membranaefaciens, Debaryomyces hansenii,
andZygosaccharomyces rouxii) [19], indicating that cinnamon
is a natural antimicrobial agent.
Gon˜i et al. described the antibacterial activity of a com-
bination of cinnamon and clove oils against Gram-positive
organisms (Listeria monocytogenes, Enterococcus faecalis,
Staphylococcus aureus, and Bacillus cereus), as well as against
Gram-negative bacteria (Salmonella choleraesuis, Escherichia
coli, Pseudomonas aeruginosa, and Yersinia enterocolitica)
[116]. A study from Hili et al. indicated that cinnamon oils
have potential action against various bacteria (Pseudomonas
aeruginosa, Staphylococcus aureus, and Escherichia coli) and
yeast (Torulopsis utilis, Schizosaccharomyces pombe, Candida
albicans, and Saccharomyces cerevisiae) [18]. A recent study
reported the activity of the aqueous extract of cinnamon
and other plants against oral microflora. Overall, the essen-
tial oil from cinnamon is more potent than other tested
plant extracts, such as Azadirachta indica and Syzygium
aromaticum [117].
10. Anticancer Activity
The aqueous extract and the fraction of cinnamon (pro-
cyanidins) from HPLC inhibit vascular endothelial growth
factor subtype 2 (VEGFR2) kinase activity, thereby inhibiting
the angiogenesis involved in cancer. The results of the study
revealed that cinnamon could potentially be used in cancer
prevention [44]. Cinnamaldehydes have been synthesized
and tested as inhibitors against angiogenesis [118]. Jeong et al.
reported that CB403, a chemical that can be synthesized from
2󸀠-hydroxycinnamaldehyde derived from cinnamaldehyde,
can inhibit tumor growth.Overall, the antitumor and growth-
inhibitory properties of CB403 in animal-based studies as
well as in cell culture-based studies indicate the potential of
cinnamon to be used as an anticancer agent [119].
Cabello et al. reported that cinnamic aldehyde inhibits
the activity of NF-𝜅B and the production of tumor necrosis
factor alpha (TNF𝛼-) induced interleukin-8 (IL-8) in A375
cells [120]. This inhibition provides additional support to the
existing unrecognized role of cinnamic acid as a potential
anticancer agent [120]. Fang and others reported the anti-
cancer effect of trans-cinnamaldehyde fromC. osmophloeum,
finding that trans-cinnamaldehyde showed potential effects
in restraining tumor cell growth and in enhancing tumor cell
apoptosis [121].
A preliminary study on cinnamon and cardamom against
azoxymethane- (AOM-) induced colon cancer in Swiss albino
mice has been conducted [122]. Treatments with the aqueous
extracts of cinnamon and cardamom augment the activities
of the detoxifying and antioxidant enzyme glutathione-s-
transferase (GST) with a concomitant reduction in lipid
peroxidation levels in animals with colon cancer compared
to controls [122]. The essential oils extracted from C. cas-
sia inhibit alpha melanocyte-stimulating hormone’s induced
melanin production, thereby suppressing oxidative stress in
murine B16 melanoma cells [7].
11. Cardiovascular Diseases
One of the active components isolated from C. cassia
named 2-methoxycinnamaldehyde (2-MCA) decreases the
expression of vascular cell adhesion molecule-1 (VCAM-
1) in TNF𝛼-activated endothelial cells, suggesting that
ischemia/reperfusion (I/R) injury is ameliorated due to the
induction of hemeoxygenase- (HO-) 1 [123]. A recent study
reported the potential effects of two compounds, cinnamic
aldehyde and cinnamic acid, isolated from C. cassia against
myocardial ischemia [124], indicating that cinnamon also has
the potential to be used to treat cardiovascular diseases.
Several studies have reported the protective effects of cin-
namaldehyde on the cardiovascular system. Cinnamophilin
is one of the important lignans isolated from C. philip-
pinensis and has been confirmed to have thromboxane A2
(TXA
2
) receptor blocking activity in rats as well as in guinea
pigs [125]. Cinnamophilin acts as a potential thromboxane
synthase inhibitor and TXA
2
receptor antagonist and may
be helpful when incorporated in the treatment of diseases
involving TXA
2
disorders [125], such as platelet aggregation
[126] and cancers [127]. Cinnamophilin mainly inhibits
thromboxane receptor-mediated vascular smoothmuscle cell
proliferation and may have the potential for use in the
prevention of vascular diseases and atherosclerosis [128].
Cinnamaldehyde produces hypotensive effects, which
are possibly mainly due to peripheral vasodilatation in
anesthetized dogs and guinea pigs [129]. The vasodilatation
induced by cinnamaldehyde in dogs lasted and remained
over the recovery period of the fall in blood pressure to the
baseline [130]. A recent study showed that cinnamaldehyde
expands rat vascular smooth muscle in an endothelium-
independent manner. The ability of cinnamaldehyde in
vasodilatory function may be because it impedes both Ca2+
influx and Ca2+ release [131]. Cinnamaldehyde averts the
progress of hypertension in types 1 and 2 diabetes by abridg-
ing vascular contractility, in addition to its insulinotropic
effect in insulin deficiency [132].
12. Cholesterol- and Lipid-Lowering Effects
The administration of cinnamon to mice positively affected
the lipid profile, whereby the high density lipoprotein (HDL)
cholesterol levels decreased, and plasma triglycerides were
reduced [27]. Another study by [133] found a reduction in the
total cholesterol, triglycerides, and low-density lipoproteins
in rats administered Cinnamomum cassia powder (15%) for
35 days. Additionally, cinnamon oils reduced the cholesterol
levels in broiler chickens [134]. A study by Khan et al.
reported that the administration of cinnamon at 1, 3, and
6 g doses per day caused a reduction in serum glucose,
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triglyceride, total cholesterol, and LDL cholesterol levels in
humans [104].
13. Advanced Glycation End Products (AGEs)
Different types of phenolic and flavonoid compounds have
been isolated from cinnamon. Epicatechin, catechin, and
procyanidin B2, which are the phenolic compounds iso-
lated from cinnamon, showed noteworthy and potentially
inhibitory activities on the formation of AGEs.These antigly-
cation activities of the phenolic compounds not only are
attributed to their antioxidant activities but also are asso-
ciated with the entrapping capabilities of reactive carbonyl
species, such as methylglyoxal (MGO), an intermediate
reactive carbonyl of AGE formation [10, 135]. The inhibition
of AGE formation by trapping the reactive carbonyl species
could be a logical therapeutic approach to treat diabetes and
its complications [10].
14. Conclusions
Cinnamon has been used as a spice in daily life without any
side effects. Several reports have dealt with the numerous
properties of cinnamon in the forms of bark, essential oils,
bark powder, phenolic compounds, flavonoids, and isolated
components. Each of these properties plays a key role in
the advancement of human health. The antioxidant and
antimicrobial activities may occur through the direct action
on oxidants or microbes, whereas the anti-inflammatory,
anticancer, and antidiabetic activities occur indirectly via
receptor-mediated mechanisms. The significant health ben-
efits of numerous types of cinnamon have been explored.
Further investigations are necessary to provide additional
clinical evidence for the traditional uses of this spice against
cancer and inflammatory, cardioprotective, and neurological
disorders.
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